4,498 reports of this reaction
3.9% of all OCTREOTIDE ACETATE reports
#1 most reported adverse reaction
DIARRHOEA is the #1 most commonly reported adverse reaction for OCTREOTIDE ACETATE, manufactured by Novartis Pharmaceuticals Corporation. There are 4,498 FDA adverse event reports linking OCTREOTIDE ACETATE to DIARRHOEA. This represents approximately 3.9% of all 115,420 adverse event reports for this drug.
OCTREOTIDE ACETATE has an overall safety score of 85 out of 100. Patients taking OCTREOTIDE ACETATE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among OCTREOTIDE ACETATE users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for OCTREOTIDE ACETATE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 4,498 FDA reports for OCTREOTIDE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.9% of all adverse event reports for OCTREOTIDE ACETATE, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking OCTREOTIDE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.